Oculis Holding AG (OCS) Selling, General & Administrative (2022 - 2026)
Powered by 
Analysis
Oculis Holding AG (OCS) Selling, General & Administrative (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.92 Bn | 131.07 Bn | 2.84 Bn | 582.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 662.10 Mn |
| 3 | Argenx Se | 63.55 Bn | 58.37 Bn | 1.37 Bn | -417.00 Mn |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn | 216.00 Mn |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | 110.21 Mn |
| 6 | BeOne Medicines | 39.98 Bn | 34.89 Bn | 1.53 Bn | 593.21 Mn |
| 7 | Alnylam Pharmaceuticals | 35.32 Bn | 32.01 Bn | 992.69 Mn | 347.92 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.59 Bn | - | 161.89 Mn |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | 247.47 Mn |
| 10 | Oculis Holding AG | 639.19 Mn | 350.31 Mn | - | -10.87 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10.87 Mn |
| Mar 31, 2026 | -10.08 Mn |
| Dec 31, 2025 | -9.70 Mn |
| Sep 30, 2025 | -8.03 Mn |
| Jun 30, 2025 | -7.39 Mn |
| Mar 31, 2025 | -6.10 Mn |
| Dec 31, 2024 | -6.28 Mn |
| Sep 30, 2024 | -6.17 Mn |
| Jun 30, 2024 | -6.93 Mn |
| Mar 31, 2024 | -5.38 Mn |
| Dec 31, 2023 | -4.89 Mn |
| Sep 30, 2023 | -4.88 Mn |
| Jun 30, 2023 | -5.34 Mn |
| Mar 31, 2023 | -4.37 Mn |
| Dec 31, 2022 | -4.61 Mn |
| Sep 30, 2022 | -2.57 Mn |
| Jun 30, 2022 | -2.88 Mn |